US Patent 11286289 T cell receptors
Patent 11286289 was granted and assigned to Adaptimmune on March, 2022 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
October 8, 2018
Date of Patent
March 29, 2022
Patent Applicant
Patent Application Number
16154192
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11286289 T cell receptors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
